A Randomized, Blinded, Single-center Study in Mild to Moderate Asthmatics Over the Age of 12 Years Who Have a Viral-mediated Exacerbation and Are Treated With Symbicort (160 mcg Budesonide/4.5 Formoterol, 2 Inhalations BID) or Pulmicort Flexhaler (160 mcg Budesonide, 2 Inhalations BID).
Phase of Trial: Phase II
Latest Information Update: 10 May 2014
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide
- Indications Asthma
- Focus Therapeutic Use
- 06 Jun 2012 Company (AstraZeneca) added to the associations field as reported by ClinicalTrials.gov record.
- 16 Oct 2010 New trial record